Apyx Medical Corp (APYX) Return on equity 2016–2025
Apyx Medical Corp (APYX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-77.1%FY2025 · since FY2016: -44.0% → -77.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -77.1% | +88.0 pp |
| FY2024 | -165.1% | -95.0 pp |
| FY2023 | -70.1% | -8.4 pp |
| FY2022 | -61.7% | -33.4 pp |
| FY2021 | -28.3% | -9.6 pp |
| FY2020 | -18.7% | +9.0 pp |
| FY2019 | -27.7% | -99.6 pp |
| FY2018 | 71.9% | +94.9 pp |
| FY2017 | -23.0% | +21.1 pp |
| FY2016 | -44.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice